Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Jan 08, 2023 1:50pm
186 Views
Post# 35209789

RE:RE:RE:Medipharm/Apotex. ANDA

RE:RE:RE:Medipharm/Apotex. ANDAAt least one of the 12 pharmaceutical companies listed in the patent infringement suit is Medipharms partner. Apotex would be my bet. ANDA's are required to be submitted to the original manufacturer which is why JAZZ is aware and launching this lawsuit which is commonplace/part of the process in generic development. Pharmaceutical companies have the right to challenge patents in court. The first corp to receive ANDA approval will get 180 day head start. 180 period where no other generics can be marketed or sold. Now the ANDA applicants are in the public realm thanks to JAZZ, it would be nice to hear from MEDIPHARM about the partnership. There are others holding drug masterfile's for CBD however MEDIPHARM Is the only corp at the mass production point, today. EPIDIOLEX GENERIC. $$$$...just a reminder 100ml bottle of epidiolex( pure naturally derived CBD ) costs Americans between 1700-2200 usd...covered by insurers..what will the financial terms be with our partner?. 
<< Previous
Bullboard Posts
Next >>